Steris Defends Sterilizer System, Awaits Further FDA Action
This article was originally published in The Gray Sheet
Executive Summary
Steris Corp. is defending its System 1 liquid chemical sterilization system in the face of recent FDA warnings, but says further regulatory sanctions, including marketing restrictions, recalls or monetary fines, are possible
You may also be interested in...
FDA Commissioner, Chief Counsel See Wiggle Room In FDA's Legal Powers
Putting FDA's aggressive enforcement plan into action will require more creativity on the part of agency lawyers, according to FDA's commissioner and new chief counsel
FDA Commissioner, Chief Counsel See Wiggle Room In FDA's Legal Powers
Putting FDA's aggressive enforcement plan into action will require more creativity on the part of agency lawyers, according to FDA's commissioner and new chief counsel
FDA To Endoscope Makers: Remove Steris Sterilizing System From Labeling
Endoscope makers who currently instruct users to clean the devices with Steris' System 1 liquid chemical sterilization system may have to file for additional FDA approval or clearance after relabeling their products to reflect an alternative reprocessing method, the agency says